Insud Pharma
Insud Pharma, a prominent player in the pharmaceutical industry, is headquartered in Spain (ES) and operates extensively across Europe and Latin America. Founded in 2007, the company has rapidly established itself as a leader in the development and manufacturing of innovative medicines, particularly in the fields of oncology, infectious diseases, and rare diseases. With a strong focus on research and development, Insud Pharma offers a diverse portfolio of products, including biosimilars and complex generics, which are distinguished by their high quality and efficacy. The company’s commitment to sustainability and patient-centric solutions has garnered recognition within the industry, positioning Insud Pharma as a trusted partner in healthcare. Notable achievements include strategic collaborations and a robust pipeline of products that continue to enhance its market presence.
DitchCarbon Score
How does Insud Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Insud Pharma's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Insud Pharma's reported carbon emissions
In 2021, Insud Pharma reported total carbon emissions of approximately 19,376,000 kg CO2e from Scope 1 and about 9,909,000 kg CO2e from Scope 2. This marked an increase in Scope 1 emissions from approximately 17,674,000 kg CO2e in 2020, while Scope 2 emissions decreased from about 24,405,000 kg CO2e in the same year. Despite these figures, Insud Pharma has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate commitments suggests a need for further action in line with industry standards for sustainability and climate responsibility. As a company headquartered in Spain (ES), Insud Pharma's emissions data reflects its global operations, highlighting the importance of addressing carbon emissions in the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | |
|---|---|---|
| Scope 1 | 17,674,000 | 00,000,000 |
| Scope 2 | 24,405,000 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Insud Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
